Dr. Jeffrey Shuren, MD, JD, director of the Center for Devices and Radiological Health (CDHR) at the Food and Drug Administration (FDA), and Dr. Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the FDA, will address attendees on the agency’s response to COVID-19, vaccines, and beyond.
SALT LAKE CITY–(BUSINESS WIRE)–BioUtah, Utah’s only trade association dedicated solely to the life sciences, announced today that Dr. Jeffrey Shuren, director of FDA’s CDHR, and Dr. Peter Marks, director of CBER, will take center stage on November 9 at this year’s virtual Utah Life Sciences Summit (ULSS). Dr. Shuren plays a key role in facilitating and advancing the development of safe and effective medical devices – a role that has become all the more visible and critical amid the COVID-19 global pandemic. Dr. Marks is responsible for assuring the safety and effectiveness of biological products, including the review of coronavirus vaccines.
To register and keep apprised of the ULSS speakers list and agenda, visit www.UtahLifeSciencesSummit.com.
The 2020 ULSS will be live streamed November 9-11 and will feature local and nationally-recognized business leaders, government officials and subject matter experts, offering insightful plenary sessions and content-rich tracks covering a range of timely and important topics. The agenda has something for everyone, including how the life sciences industry is addressing COVID-19, industry and investor outlook, workforce considerations, diversity and the always popular regulatory track. The online programming will also include an important announcement on a Salt Lake City innovation center as well as a special awards presentation on November 11.
“Although we won’t be together in person, Utah’s life sciences community is unified in its vision to continue to innovate, collaborate and build a world-class bioscience hub,” said Brandi Simpson, chair of the BioUtah board of directors. “Our focus, even during this time of uncertainty, is to advance healthcare and make a difference in patients’ lives.”
“This passion and drive to improve lives is evident in the more than 45 companies in the state that are fighting COVID-19 by developing medical technologies, diagnostics, therapies and delivering on personal protection equipment,” said Kelvyn Cullimore, president and CEO of BioUtah. “Our virtual conference will look at our industry from both a pandemic and post-pandemic landscape.”
The conference promises the same inspirational and valuable experience as in the past – just in a virtual setting.
About BioUtah
BioUtah is an independent 501(c)(6) trade association serving Utah’s life sciences industry. Its member companies reflect a broad spectrum of the industry with strengths in medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, and advanced diagnostics, amongst others; and are a key driver of Utah’s economy.
Contacts
Denise Bell
BioUtah
denise@bioutah.org
202-680-3030